The Dairy Tech for DHT and the Heartburn Cure
India’s dairy tech industry is the largest in the world, with more than 1,000 companies offering services to the dairy industry.
It is a growing sector that is also seeing a dramatic growth in its share in the food and beverage market.
With the global market for dairy products set to explode in the next few years, the dairy tech sector has been on a roll.
Its products, however, are not without their share of problems.
The latest in this category is the use of levaquin dairy proteins for the treatment of heartburn.
Levaquin is an animal feed derived from sheep that has been found to increase the release of adrenaline in the body, according to a report by the World Health Organization.
This results in a temporary increase in heart rate.
The International Dairy Science Association (IDSA) has said that the use to treat heartburn has been associated with a range of health problems including obesity, depression, heart disease and cancer.
Levadans dairy proteins, however have a higher concentration of DHT in them than other cow’s milk proteins.
This means that it is possible to overdose on the protein.
This has led to the deaths of several people in India who have consumed levaquin products.
The government has banned levaquin and its use in India and some other countries including the United Kingdom, Germany and Italy.
The European Union has also put levaquin on its list of banned food allergens.
The European Union also has a ban on levaquin in dairy products.
However, the IDSA has said it is concerned about the safety of levadans consumption.
The IDSA, which is an umbrella organisation for over 10,000 dairy producers, said levaquin was being used as a food additive for reasons including to treat obesity and to increase appetite in animals.
“This raises serious concerns about the potential health risks associated with consumption of levadedisan in humans,” the IDAS said in a statement.
“The IDAS and its Member States are working to address the safety and efficacy of levadingisan for the benefit of consumers and for scientific and public health research.”
A statement by the IDA said it was committed to ensuring that the safety assessment of levadeisan products was based on solid scientific evidence.
However, the statement also said it wanted to emphasise that levadeusan should not be taken for medical purposes.
In India, the government has been working on ways to reduce the use and consumption of dairy products as part of its national diet plan.